Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 10019-956

10 FDA label images from Baxter Healthcare Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

Cyclophosphamide Structural Formula (Image 01)
Chemical structure diagram of cyclophosphamide, showing its molecular arrangement including a cyclic moiety, phosphorus atom, and other functional groups as labeled.*
FDA Label Image

Cyclophosphamide Baxter Representative Container Lbl 10019-955-50 (Image 02)

Cyclophosphamide Baxter Representative Container Lbl 10019-955-50 (Image 02)
Label for Cyclophosphamide for Injection, USP 500 mg/vial, a cytotoxic agent by Baxter Healthcare Company. It states the product is for single dose use, sterile, non-pyrogenic, and for parenteral use. Instructions for infusion or direct injection dilution with 25 mL of appropriate sterile solution are noted. Storage instructions and regulatory references are included.*
FDA Label Image

Cyclophosphamide Baxter Representative Carton Lbl 10019-955-01 Panel 1 Of 2 (Image 03)

Cyclophosphamide Baxter Representative Carton Lbl 10019-955-01 Panel 1 Of 2 (Image 03)
Packaging label for Cyclophosphamide injection, USP, 500 mg per vial, manufactured by Baxter Healthcare Company. The label indicates it is for intravenous or direct injection use, single-dose vial, requiring dilution before use. Storage instructions and cytotoxic agent warnings are included. The product is sterile and non-pyrogenic for parenteral use.*
FDA Label Image

Cyclophosphamide Baxter Representative Carton Lbl 10019-955-01 Panel 2 Of 2 (Image 04)

Cyclophosphamide Baxter Representative Carton Lbl 10019-955-01 Panel 2 Of 2 (Image 04)
Cyclophosphamide for Injection, USP 500 mg per vial is shown on a cardboard carton label. The label states the drug must be diluted for intravenous infusion or can be used for direct injection. It is a single-dose vial manufactured by Baxter Healthcare Corporation, Deerfield, IL, made in Germany. The NDC is 10019-955-01.*
FDA Label Image

Cyclophosphamide Baxter Representative Container Lbl 10019-956-16 (Image 05)

Cyclophosphamide Baxter Representative Container Lbl 10019-956-16 (Image 05)
Label for Cyclophosphamide for Injection, USP, 1 gram per vial, a cytotoxic agent for single dose use, sterile and non-pyrogenic for parenteral administration. The label indicates it is manufactured by Baxter Healthcare Company. Instructions for reconstitution with sterile water or sodium chloride injection for intravenous or direct injection use are included.*
FDA Label Image

Cyclophosphamide Representative Baxter Carton Lbl 10019-956-01 Panel 1 Of 2 (Image 06)

Cyclophosphamide Representative Baxter Carton Lbl 10019-956-01 Panel 1 Of 2 (Image 06)
Packaging label for Cyclophosphamide for Injection, USP, 1 gram per vial, powder for solution. The label indicates the drug is for intravenous or direct injection use and must be diluted prior to infusion. It is a single-dose vial labeled as prescription only (Rx only). The labeler is Baxter Healthcare Company, with manufacturing in Germany. The label includes storage instructions and warnings emphasizing its cytotoxic agent properties and sterile, non-pyrogenic status for parenteral use.*
FDA Label Image

Cyclophosphamide Representative Baxter Carton Lbl 10019-956-01 Panel 2 Of 2 (Image 07)

Cyclophosphamide Representative Baxter Carton Lbl 10019-956-01 Panel 2 Of 2 (Image 07)
Packaging label for Cyclophosphamide for Injection, USP 1 gram per vial by Baxter Healthcare Company. The label specifies that the vial is single-dose, must be diluted for IV infusion or used for direct injection. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA, made in Germany. The label includes NDC 10019-956-01 and the statement Rx only.*
FDA Label Image

Cyclophosphamide Baxter Representative Container Lbl 10019-957-11 (Image 08)

Cyclophosphamide Baxter Representative Container Lbl 10019-957-11 (Image 08)
Label for Cyclophosphamide for Injection, USP, 2 gram per vial, sterile powder for solution. The label indicates the product is a cytotoxic agent for single dose use, non-pyrogenic, for parenteral use. It includes instructions for IV infusion and direct injection preparation. The labeler is Baxter Healthcare Company, manufactured in Germany.*
FDA Label Image

Cyclophosphamide Representative Baxter Carton Lbl 10019-957-01 Panel 1 Of 2 (Image 09)

Cyclophosphamide Representative Baxter Carton Lbl 10019-957-01 Panel 1 Of 2 (Image 09)
Cyclophosphamide for Injection, USP 2 gram/vial powder for solution single dose vial packaging label. The label includes dosing instructions for IV infusion and direct injection, storage conditions, and cytotoxic agent warnings. Manufactured by Baxter Healthcare Corporation.*
FDA Label Image

Cyclophosphamide Representative Baxter Carton Lbl 10019-957-01 Panel 2 Of 2 (Image 10)

Cyclophosphamide Representative Baxter Carton Lbl 10019-957-01 Panel 2 Of 2 (Image 10)
The image shows the carton label for Cyclophosphamide for Injection, USP, 2 gram per vial. The label indicates the product is a single dose vial that must be diluted for intravenous infusion or direct injection use. It is labeled with NDC 10019-957-01 and is manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, made in Germany. The carton also features a barcode and a recycling symbol for the folding box.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.